Proteimax BIO Technology

Company Overview

Snapshot

Founded in December 2025, Proteimax BIO Technology operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing peptide-based solutions for health and agricultural challenges.

Business overview

Proteimax BIO Technology specializes in discovering and commercializing naturally occurring intracellular peptides for human and animal health. Its core technology involves lead peptides like Pep19, formulated as functional food ingredients to reduce visceral fat, improve metabolic markers, and enhance sleep quality. The company also has additional candidates targeting cell proliferation and neuroprotection. Proteimax partners with food, beverage, supplement manufacturers, and animal health companies to integrate its proprietary peptides into differentiated products, serving the Health Tech & Life Sciences sector, specifically within Pharma & Medical Biotechnology and Drugs Discovery & Development.

Company Intelligence Q&A

What is Proteimax BIO Technology's primary focus?

Proteimax BIO Technology focuses on discovering and commercializing naturally occurring intracellular peptides to address significant health and agricultural challenges.

What is the lead product candidate for Proteimax BIO Technology?

The company's lead peptide, Pep19, is formulated as a functional food ingredient designed to reduce visceral fat, improve metabolic markers, and enhance sleep quality.

Which markets does Proteimax BIO Technology serve?

Proteimax BIO Technology serves the human and animal health markets, partnering with food, beverage, and supplement manufacturers, as well as animal health players.

What is the current product development stage of Proteimax BIO Technology?

Proteimax BIO Technology's product is currently in the Clinical Trial stage, supported by extensive preclinical work and early-stage clinical data.

When was Proteimax BIO Technology founded?

Proteimax BIO Technology was founded in December 2025.